XML 58 R45.htm IDEA: XBRL DOCUMENT v3.25.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of stock-based compensation included in its condensed consolidated statements of operations and comprehensive income (loss)

Years Ended December 31, 

(in thousands)

2025

  ​ ​ ​

2024

Research and development

$

3,037

$

8,021

General and administrative

 

7,595

11,896

Cost of revenue

 

339

18

Total

$

10,971

$

19,935

 

Schedule of share-based compensation expense by award type

Years Ended December 31, 

(in thousands)

2025

  ​ ​ ​

2024

RSUs

$

8,359

$

12,733

PSUs

1,380

2,885

RSAs

1,199

1,950

Stock options

33

370

Earn-Out Restricted Shares

1,997

Total

$

10,971

$

19,935

 

Summary of RSU activity

Number of Shares

Weighted Average Fair Value

Outstanding at December 31, 2023

6,359,474

$

3.71

Granted

11,729,289

$

1.32

Vested

(2,413,455)

$

4.14

Forfeited and canceled

(2,392,385)

$

1.95

Outstanding at December 31, 2024

13,282,923

$

1.83

Granted

9,029,793

$

0.75

Gross vested units

(5,209,010)

$

2.40

Forfeited and canceled

(3,219,825)

$

1.31

Outstanding at December 31, 2025

13,883,881

$

1.03

 

Summary of fair value assumptions for performance stock units

  ​ ​ ​

2024

Expected term (in years)

3.0

Risk free rate

4.06%

Expected volatility

90.0%

Expected dividends

0%

Stock price

$

1.36

 

Summary of PSU activity

Number of Shares

Weighted Average Fair Value

Outstanding at December 31, 2023

3,364,810

$

3.60

Granted

3,637,556

$

0.42

Vested

$

Forfeited and canceled

(1,029,316)

$

6.96

Outstanding at December 31, 2024

5,973,050

$

1.34

Granted

264,469

$

2.32

Vested

$

Forfeited and canceled

(274,365)

$

1.31

Outstanding at December 31, 2025

5,963,154

$

1.39

 

Summary of stock option activity

Number of Options

Weighted Average Exercise Price

Weighted Average Remaining Contractual Term
(in years)

Aggregate Intrinsic Value
(in millions)

Outstanding at December 31, 2023

13,619,793

$

0.17

6.8

$

22.7

Granted

$

Exercised

(6,507,475)

$

0.16

$

4.0

Forfeited and canceled

(1,049,208)

$

0.19

Outstanding at December 31, 2024

6,063,110

$

0.19

5.5

$

12.2

Granted

$

Exercised

(614,255)

$

0.12

$

0.9

Forfeited and canceled

(17,130)

$

0.39

Outstanding at December 31, 2025

5,431,725

$

0.19

4.7

$

8.8

Vested, December 31, 2025

5,431,725

$

0.19

4.7

$

8.8

Vested or expected to vest, December 31, 2025

5,431,725

$

0.19

4.7

$

8.8

 

Restricted Stock  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of restricted share activity

Number of Shares

Weighted Average Fair Value

Outstanding at December 31, 2023

649,567

$

5.05

Granted

$

-

Vested

(386,964)

$

5.05

Forfeited and canceled

(7,145)

$

5.07

Outstanding at December 31, 2024

255,458

$

5.04

Granted

$

Vested

(253,358)

$

5.04

Forfeited and canceled

(2,100)

$

5.30

Outstanding at December 31, 2025

$

 

Earn-out Shares, Earn-out Restricted Shares  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of restricted share activity

Number of Shares

Weighted Average Fair Value

Outstanding at December 31, 2023

1,619,998

$

6.53

Granted/vested

$

Forfeited and canceled

(854,008)

$

6.53

Outstanding at December 31, 2024

765,990

$

6.53

Granted/vested

$

Forfeited and canceled

(23,710)

$

6.53

Outstanding at December 31, 2025

742,280

$

6.53